127,669 articles
Apennine culture
The Apennine culture was a Bronze Age archaeological culture of peninsular Italy, known above all for its hand-made pottery, flourishing from the 16th to 13th centuries BCE.
Apepi
Apepi, also Apophis or Ipepi, was a Hyksos king of the Fifteenth Dynasty who ruled from Avaris around 1585 to 1542 BC and fought the Theban kings Seqenenre and Kamose.
Aperanat
Aperanat, also written Aper-Anati, was a ruler of Egypt's Second Intermediate Period known from a single scarab in the Petrie Museum bearing the title heqa khasut, meaning ruler of foreign lands.
Aperel
Aperel ('Aper-El, also written 'Aperia) was a vizier of Egypt under Amenhotep III and probably Akhenaten, c. 1391–1353 BC, known from his rock-cut tomb at Saqqara, reached in 1987.
Aperia Technologies, Inc.
Aperia Technologies, Inc. is a tire-management technology company founded in 2010 in Burlingame, California, known for its self-powered Halo automatic tire inflation system for commercial trucks and trailers.
Apex.ai
Apex.ai is a German-American automotive software company, founded in 2017 by Jan Becker and Dejan Pangercic, that develops safety-certified middleware for vehicles and mobile machines.
Aphantasia
Aphantasia is the reduced or absent ability to form voluntary mental imagery, coined in 2015 by Adam Zeman, Michaela Dewar, and Sergio Della Sala; opposite extreme hyperphantasia; prevalence about 3.9%; not a DSM disorder; assessed mainly by VVIQ and binocular rivalry.
Aphea.Bio
Aphea.Bio is a Belgian agricultural biotechnology company based in Ghent, founded in 2017 as a spin-off of VIB with Ghent University and KU Leuven, developing microbial biostimulants and biocontrol products.
Aphilas
Aphilas, also Aphilas Bisi Dimele, was a king of Aksum in the early 4th century AD, known chiefly from his coinage, including the only Aksumite fractional gold denominations.
Aphorism
Aphorism (Greek aphorismos, 'definition') is a concise statement of a general truth or principle, from Hippocrates' medical Aphorisms; distinct from proverbs, maxims, and epigrams by authorship and generality.
Aphrodisia (φροδίσια)
Aphrodisia (τὰ Ἀφροδίσια): festivals of Aphrodite celebrated across the Greek world, especially at Paphos in Cyprus, and also the ordinary Greek plural for sexual pleasures; attested by Xenophon, Athenaeus, Tacitus, and LSJ.
Aphrodite (Ἀφροδίτη)
Aphrodite (Ἀφροδίτη), Greek goddess of love, beauty, and procreation, Roman Venus; of Near Eastern origin via Cyprus and Astarte/Ishtar, daughter of Zeus and Dione or born from sea foam, worshipped at Cyprus, Cythera, and Corinth.
Aphsad inscription of Adityasena
The Aphsad inscription of Adityasena (अप्षाड शिलालेख) is a stone inscription of the Later Gupta king Adityasena, found at Aphsad in Bihar and now held in the British Museum.
Apiashal
Apiashal is an early Assyrian ruler known only from later copies of the Assyrian King List, where he is the last of seventeen "kings who lived in tents".
Apil-kin
Apil-kīn was a shakkanakku, or governor and ruler, of Mari on the Euphrates around 2126–2091 BC; his daughter Tarām-Uram married the Ur king Shulgi.
Apil-Sin
Apil-Sîn was the fourth Amorite king of the First Dynasty of Babylon, reigning from 1830 to 1813 BC, the father of Sin-muballit and grandfather of Hammurabi.
Apilkin
Apilkin was a king of the Gutian dynasty of Sumer, known essentially from a single line in the Sumerian King List assigning him a 3-year reign between Kurum and Laerabum.
Āpirana Ngata
Sir Āpirana Ngata (1874–1950), Ngāti Porou leader and first Māori university graduate, MP for Eastern Māori 1905–1943 and Native Minister 1928–1934, built state-funded Māori land development schemes and led Māori cultural revival through Ngā Mōteatea and the Rotorua school of Māori arts.
Apis (deity)
Apis (Hapi, Hep), the sacred bull deity of Memphis in ancient Egypt, living manifestation (ba) of Ptah; one bull at a time, identified by distinctive markings, buried as Osiris-Apis in the Saqqara Serapeum, basis of Serapis.
Apis bull stelae
Apis bull stelae, also called Serapeum stelae, are dated stone slabs set up in the Serapeum at Saqqara to commemorate sacred Apis bulls and their burials.
Apnimed, Inc.
Apnimed, Inc. is a Cambridge, Massachusetts pharmaceutical company developing AD109 (Oxnimbi), a once-daily oral pill for obstructive sleep apnea, with an FDA decision expected in 2027.
Apocalypse
An apocalypse, from the Greek apokalypsis meaning "uncovering," is a work of revelatory literature in which divine secrets about the end times are disclosed to a human recipient.
Apocalypse of Peter
The Apocalypse of Peter, also called the Revelation of Peter, is an early second-century apocryphal text in which the risen Christ shows Peter the punishments of the wicked.
Apocalyptic literature
Apocalyptic literature is a genre of Jewish and early Christian texts, written from the third century BCE to the second century CE, revealing the end times.
Apocalypticism
Apocalypticism, also called apocalyptic eschatology, is belief in an impending world destruction or radical transformation of the social, political, or religious order, expressed in texts like Daniel and Revelation.
Apocrypha
The Apocrypha is a set of Jewish religious writings from about 200 BC to AD 100, included in Catholic and Orthodox Bibles but not in Protestant ones.
Apocrypha in Old Rus'
Apocrypha in Old Rus' (Апокрифы Древней Руси) are non-canonical religious tales and books that circulated in medieval Rus' manuscript culture from the 11th to the 17th century.
Apocryphal Acts of the Apostles
The Apocryphal Acts of the Apostles are early Christian narratives, written from the late second century onward, recounting the apostles' missionary journeys, miracles, and martyrdoms outside the New Testament.
Apocryphon of John
The Apocryphon of John, also called the Secret Book of John, is a Sethian Gnostic text attributed to John son of Zebedee, surviving in four Coptic copies.
Apogee Therapeutics
Apogee Therapeutics was a US clinical-stage biotechnology company founded in 2022 to develop extended-half-life antibodies for atopic dermatitis, asthma, and COPD; AbbVie acquired it in 2026 for about $10.9 billion.